ArticleCardiology research and practice2013
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.
Article in Cardiology research and practice, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 72 citations in OpenAlex.
- Accumulation of chronic conditions in patients aged <65 years diagnosed with atrial fibrillation.Heart rhythm · 2026Article
- Safety and Feasibility of a CT-Based Pathway for Left Atrial Appendage Assessment Prior to Inpatient Cardioversion: A Single-Center Experience.Clinical cardiology · 2026Article
- Increased risk of atrial fibrillation in young adults with gout: a nationwide cohort study.Frontiers in cardiovascular medicine · 2026Article
- Prevalence and Factors Associated With Atrial Fibrillation Among Young Patients With Ischemic Stroke.Journal of the American Heart Association · 2025Observational
- Pharmacological Cardioversion Versus Electrical Cardioversion in the Acute Treatment of Atrial Fibrillation in the Emergency Department: The Recufa-Hula Register.Journal of clinical medicine · 2025Article
- Increased risk of atrial fibrillation in uterine fibroid patients: a nationwide population-based study.Scientific reports · 2025Article
- Prevalence of Genetic Variants Associated with Atrial Fibrillation Risk in the Asymptomatic Young Adult Population.Medicina (Kaunas, Lithuania) · 2025Article
- Left Atrial Appendage Thrombus in Low CHA2DS2VASc Score in Persistent Atrial Fibrillation.Cureus · 2025Article
- Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis.European journal of neurology · 2025Article
- Early-Onset Atrial Fibrillation Complicated by Substance Use Disorder and Psychiatric Comorbidities: A Case Report.Cureus · 2024Article
- Article
- Rate Versus Rhythm Control for Atrial Fibrillation.The Permanente journal · 2024Article
- Global burden of atrial fibrillation/flutter: Trends from 1990 to 2019 and projections until 2044.Heliyon · 2024Article
- DNA Methylation and Telomeres-Their Impact on the Occurrence of Atrial Fibrillation during Cardiac Aging.International journal of molecular sciences · 2023Review
- Risk Factors Associated With Atrial Fibrillation in Elderly Patients.Journal of clinical medicine research · 2023Article
- Safety and efficacy of cryoablation for atrial fibrillation in young patients: A multicenter experience in the 1STOP project.Clinical cardiology · 2023Article
- Risk of left atrial appendage thrombus in older patients with atrial fibrillation.Archives of medical science : AMS · 2023Article
- Habitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea.JAMA network open · 2022Article
- A case report of atrial fibrillation in early adulthood: dig deeper.European heart journal. Case reports · 2022Article
- Non-alcoholic Fatty Liver Disease and the Risk of Incident Atrial Fibrillation in Young Adults: A Nationwide Population-Based Cohort Study.Frontiers in cardiovascular medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
Abstract
The incidence and prevalence of atrial fibrillation (AF) are projected to increase significantly worldwide, imposing a significant burden on healthcare resources. The disease itself is extremely heterogeneous in its epidemiology, pathophysiology, and treatment options based on individual patient characteristics. Whilst ageing is well recognised to be an independent risk factor for the development of AF, this condition also affects the young in whom the condition is frequently symptomatic and troublesome. Traditional thinking suggests that the causal factors and pathogenesis of the condition in the young with structurally normal atria but electrophysiological "triggers" in the form of pulmonary vein ectopics leading to lone AF are in stark contrast to that in the elderly who have AF primarily due to an abnormal substrate consisting of fibrosed and dilated atria acting in concert with the pulmonary vein triggers. However, there can be exceptions to this rule as there is increasing evidence of structural and electrophysiological abnormalities in the atrial substrate in young patients with "lone AF," as well as elderly patients who present with idiopathic AF. These reports seem to be blurring the distinction in the pathophysiology of so-called idiopathic lone AF in the young versus that in the elderly. Moreover with availability of improved and modern investigational and diagnostic techniques, novel causes of AF are being reported thereby seemingly consigning the diagnosis of "lone AF" to a rather mythical existence. We shall also elucidate in this paper the differences seen in the epidemiology, causes, pathogenesis, and clinical features of AF in the young versus that seen in the elderly, thereby requiring clearly defined management strategies to tackle this arrhythmia and its associated consequences.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.